The principal goal was To guage the efficacy in the vaccine versus placebo in lowering cocaine use. Secondary aims involved confirming vaccine immunogenicity by IgG anti-cocaine antibody stages and assessing the safety and tolerability of vaccination via a 20 week review and at 24 7 days abide by-up. Cocaine eye https://rickeyx197stt6.idblogz.com/profile